ALC
Alcon Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · CH
$70.58
−2.08%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
18.5x
EV/EBITDA
21.6x
Market Cap
$34.12B
MomentumView details →
1D Return
−2.08%
YTD Return
−10.16%
RSI (14)
44.7
ValuationView details →
P/E (Fwd)
18.5x
EV/EBITDA
21.6x
Market Cap
$34.12B
RSI (14)
44.7
MomentumView details →
1D Return
−2.08%
YTD Return
−10.16%
SummaryUpdated Jun 1, 2026
Alcon Inc. (NYSE:ALC) is a Swiss-headquartered eye care company that was spun off from Novartis and went public in 2019. Founded in 1945, Alcon has grown to become one of the world's largest dedicated eye care companies, focusing exclusively on developing, manufacturing, and distributing products for eye care professionals and their patients globally. The company operates through two primary business segments: Surgical and Vision Care, serving ophthalmologists, optometrists, and consumers worldwide with a comprehensive portfolio of eye care solutions.
Similar companies
Latest newsMore news →